Search

everythinglearnresearchcommunity

for

Search:↓

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Stromal stem cells may help heal wounds by becoming structural cells or affecting the immune system, but more research is needed to understand how.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Non-immune factors play a significant role in alopecia areata.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Telocytes in the scalp may help with skin regeneration and maintenance.

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

Immune cells are crucial for hair growth and preventing hair loss.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

A woman with lupus had blood cell destruction, treated successfully with medication.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Researchers created a skin graft that senses blood glucose and could treat diabetes using CRISPR-edited stem cells.